에 대한 최신 뉴스 GRAIL (NASDAQ:GRAL) 주식

GRAIL

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

News

Movers

GRAL

캘리포니아주 멘로파크에 본사를 둔 미국의 생명공학 회사인 그레일(NASDAQ:GRAL)의 주식은 회사가 임상 실험 연구 기업인 퀘스트 다이아그노스틱스(NYSE:DGX)와의 새로운 협업을 발표한 후 수요일 18% 이상 급등 마감했다.

수요일 그레일 주식이 18% 이상 급등 마감: 무슨 일이 있었나?

GRAIL Inc

GRAIL INC COM

Dakota Gold Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DC#NASDAQ">DC</a>) shares are trading lower by 8.1% to $2.81 during Friday&#8217;s session following its announcement and pricing of a <a href="https://www.benzinga.com/pressreleases/25/03/44429330/dakota-gold-announces-pricing-of-offering-of-common-stock-for-gross-proceeds-of-approximately-35-mi">$35 million common stock offering</a>.
What To Know: Dakota Gold has priced its public offering of 12.4 million common shares at $0.001 par value, expected to close by March 24, pending regulatory approval.
The offering will generate approximately $35 million in gross proceeds, with an option for underwriters to purchase an additional 1.86 million shares, potentially raising total proceeds to $40 million. The funds will support working capital and general corporate purposes.
What Else: The total gross proceeds of $35 million from 12.4 million shares suggest an estimated offering price of approximately $2.82 per share.
BMO Capital Markets leads the offering, with Canaccord Genuity, CIBC Capital Markets, RBC Capital Markets, Scotiabank and Agentis Capital Markets as co-managers. Underwriters have 30 days to exercise their option for additional shares.
Read Also: <a href="https://www.benzinga.com/25/03/44439169/monster-equity-inflows-say-no-one-really-believes-trade-war-bank-of-americas-hartnett-says">&#8216;Monster Equity Inflows Say No One Really Believes Trade War,&#8217; Bank Of America&#8217;s Hartnett Says</a>
<h2 class="wp-block-heading">How To Buy DC Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Dakota Gold&#8217;s case, it is in the Materials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, DC has a 52-week high of $3.50 and a 52-week low of $1.84.

Why Dakota Gold Shares Are Trading Lower

<a href="https://www.bloomberg.com/news/articles/2025-03-21/uk-considers-cutting-online-sales-tax-for-us-tariff-carve-out" title="https://www.bloomberg.com/news/articles/2025-03-21/uk-considers-cutting-online-sales-tax-for-us-tariff-carve-out">https://www.bloomberg.com/news/articles/2025-03-21/uk-considers-cutting-online-sales-tax-for-us-tariff-carve-out</a>

Macro Economic Events

Politics

Global

Economics

General

'UK Considers Cutting Online Sales Tax For US Tariff Carve-Out' - Bloomberg News

WIIM

RDDT

Reddit shares are trading higher after Needham reiterated a Buy on the stock, and maintained a $220 price target.

TC Biopharm PLC &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBP#NASDAQ">TCBP</a>) shares are trading lower by 62% to 58 cents during Friday&#8217;s session after the company announced the <a href="https://www.benzinga.com/pressreleases/25/03/n44438018/tcbp-announces-transition-from-nasdaq-to-otc-markets">transition</a> from Nasdaq to OTC markets.
What To Know: TC BioPharm a clinical-stage biotech firm, announced that Nasdaq has decided to delist its securities for failing to meet the $1.00 minimum bid price requirement under Rule 5550(a)(2). 
The company received notice of this decision on Thursday. TC BioPharm, which focuses on allogeneic gamma-delta T-cell therapies for cancer and other diseases, is now working on an appeal to Nasdaq in an effort to regain compliance.
Read Also: <a href="https://www.benzinga.com/25/03/44439169/monster-equity-inflows-say-no-one-really-believes-trade-war-bank-of-americas-hartnett-says">&#8216;Monster Equity Inflows Say No One Really Believes Trade War,&#8217; Bank Of America&#8217;s Hartnett Says</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, has a 52-week high of $523.20 and a 52-week low of $0.54.

TCBP

Why TC Biopharm (TCBP) Stock Is Down Over 60% Today

<a href="https://www.bloomberg.com/news/articles/2025-03-21/coinbase-in-advanced-talks-to-buy-derivatives-venue-deribit-coin" title="https://www.bloomberg.com/news/articles/2025-03-21/coinbase-in-advanced-talks-to-buy-derivatives-venue-deribit-coin">https://www.bloomberg.com/news/articles/2025-03-21/coinbase-in-advanced-talks-to-buy-derivatives-venue-deribit-coin</a>

COIN

'Coinbase Is In Advanced Talks To Buy Derivatives Venue Deribit' - Bloomberg News

Shares of major Europe-related ETFs are trading lower, led by a decline in travel stocks, after the closure of Heathrow Airport following a fire at a nearby electrical substation.

Trading Ideas

MLGO

MicroAlgo Shares Halted On Circuit Breaker To The Upside, Stock Now Down -23.4%

After nearly collapsing during the last crypto downturn, <a href="https://www.benzinga.com/money/best-crypto-loans-and-lending-platforms">digital asset lending</a> is making a comeback, with a new generation of lenders re-entering the market.
What Happened: Both traditional financial institutions and blockchain-native companies are reintroducing capital to meet the growing need for liquidity and leverage within the sector, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-03-21/cantor-leads-a-new-boom-in-lending-to-debt-hungry-crypto-firms?embedded-checkout=true">reported</a>.
Over the past month, several major players have unveiled new lending initiatives. 
Cantor Fitzgerald has launched a Bitcoin lending business backed by $2 billion in capital, signaling Wall Street's renewed interest. 
At the same time, Blockstream has secured billions for its crypto lending funds, while Xapo Bank has begun issuing Bitcoin-collateralized loans of up to $1 million.
"We're seeing larger institutions taking the lead this time around," said David Mercer, CEO of LMAX Group. "More banks are gearing up to provide financing solutions for major institutions in the crypto space."
The boom in crypto lending during the 2021 bull market saw firms like Genesis, BlockFi and Celsius offering unsecured loans to trading desks and hedge funds. 
However, as crypto prices tanked, those lenders collapsed, dragging liquidity out of the market.
Their bankruptcies left many crypto businesses scrambling to access short-term financing.
Rob Hadick, general partner at venture firm Dragonfly, pointed out that the market has struggled to replace those lenders. "There's been a vacuum when it comes to firms offering leverage," he said. "The absence of solid risk management across the industry has been a persistent problem."
With traditional banks largely avoiding crypto lending under regulatory scrutiny in recent years, crypto exchanges and brokers have tried to fill the gap. 
Bitstamp USA CEO Bobby Zagotta believes that may change under the Trump administration, which has signaled a more favorable stance on digital asset markets.
"We expect clearer regulations, which could give banks the confidence to engage," Zagotta said.
Also Read: <a href="https://www.benzinga.com/25/03/44433988/tether-is-now-too-big-to-fail-says-anthony-pompliano-citing-its-growing-role-in-us-treasury-markets">Tether Is Now &#8216;Too Big To Fail,&#8217; Says Anthony Pompliano: Here&#8217;s Why</a>
Why It Matters: Today, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)-backed loans remain one of the most common financing tools for crypto businesses. Yet, volatility in crypto prices has kept many large financial institutions cautious.
Adam Sporn, who leads institutional sales at BitGo, explained, "Most borrowing demand we see today is for cash. The lack of large banks lending has held back the space."
The shift in sentiment is being attributed to signals from policymakers, including President Trump, who has reiterated his administration's support for crypto-friendly regulations and stablecoin legislation. 
According to Hadick, "There's growing enthusiasm among traditional lenders, who now feel reassured by the current regulatory environment."
As new lenders step in, the terms of crypto credit are also changing. Loan-to-value ratios are lower, requiring borrowers to post more collateral upfront to secure loans and reduce default risks.
For now, undercollateralized lending remains rare. "If we do see the return of undercollateralized credit for prime brokers and institutions, that will be a key step in improving liquidity across the board," Hadick added.
While many welcome the return of institutional lenders to crypto, some remain cautious about systemic risks. 
Austin Campbell, CEO of stablecoin firm WSPN USA and a professor at NYU, noted, "Crypto alone can't reinvent the lending playbook overnight. Bringing in traditional credit expertise is essential to stabilize the sector."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44423417/record-breaking-high-risk-bitcoin-whale-allegedly-outed-as-uk-fraudster-with-casino-theft-history">Record-Breaking High-Risk Bitcoin Whale Allegedly Outed As UK Fraudster With Casino Theft History</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Wall Street And Crypto Firms Revive Lending Market After Industry Shakeout

IPOs

NUTR

NusaTrip IPO Price Estimated Between $4.00 And $5.00 Per Share

On Friday, JPMorgan analyst Christopher Horvers reiterated the Neutral rating on Academy Sports and Outdoors, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>), <a href="https://www.benzinga.com/quote/ASO/analyst-ratings" target="_blank" rel="noreferrer noopener">raising the price forecast to $54 from $52.</a>
Yesterday, the firm reported fourth-quarter adjusted earnings per share of $1.96,&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44421964/academy-sports-beats-q4-eps-estimates-comparable-sales-dip-3" rel="noreferrer noopener">beating the street view of $1.83</a>.&nbsp;Quarterly sales of $1.676 billion (down 6.6% year over year) missed the analyst consensus estimate of $1.677 billion by a hairline.
The analyst notes that Academy Sports has made progress in improving new store site selection for the second half of 2024, following underwhelming performance when it initially started its unit growth story in 2022.
Also Read: <a href="https://www.benzinga.com/government/regulations/25/03/44440713/wall-street-trims-losses-as-boeing-eyes-best-week-in-nearly-2-years-whats-driving-markets-friday" target="_blank" rel="noreferrer noopener">Wall Street Trims Losses As Boeing Eyes Best Week In Early 2 Years: What&#8217;s Driving Markets Friday?</a>
Furthermore, the company's IT improvements and plans show promise in enhancing the performance of its existing stores, Horvers writes.
Academy Sports is also expanding its Nike, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) product assortment to 145 of its 300+ locations, as well as on its website, starting this April, aiming to compete with Dick&#8217;s Sporting Goods Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) for brand access.
However, Horvers points out that the macroeconomic environment presents challenges for Academy Sports, particularly compared to competitors like Dick&#8217;s Sporting, due to its higher exposure to lower-income consumers.
Despite this, the analyst remains neutral on Academy Sports, acknowledging its attractive valuation but expressing &#8220;uncertainty&#8221; about how much growth the company can achieve given the current market conditions.
The analyst models 1Q/FY25 comps of -3.5%/flat, respectively.
Price Action: ASO shares are trading higher by 1.14% to $47.96 at last check Friday.
Read now:
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/03/44435609/sp-500-could-soar-12-by-year-end-but-only-if-recession-is-avoided-goldman-sachs-says" target="_blank" rel="noreferrer noopener">S&amp;P 500 Could Soar 12% By Year-End—But Only If Recession Is Avoided, Goldman Sachs Says</a></li>
</ul>

Equities

Markets

Analyst Ratings

Academy Sports' Growth Potential Uncertain Amid Macroeconomic Challeneges: Analyst Explains Why

Fearnleys analyst Truls Olsen initiates coverage on Flowco Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOC#NYSE">FLOC</a>) with a Buy rating and announces Price Target of $34.

Price Target

Initiation

FLOC

Fearnleys Initiates Coverage On Flowco Holdings with Buy Rating, Announces Price Target of $34

JPMorgan analyst Tessa T Romero remains engaged in discussions about Dyne Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) and its DYNE-101 program in DM1, addressing questions about the next step <a href="https://www.benzinga.com/general/biotech">and potential value creation.</a>
Romero&#8217;s note, issued Thursday, highlights Dyne&#8217;s plan to initiate a global Registrational Expansion Cohort in<a href="https://www.benzinga.com/25/01/42923575/why-is-neuromuscular-focused-dyne-therapeutics-stock-trading-lower-on-friday"> the first half of 2026</a>. This move aims to support a submission for U.S. Accelerated Approval based on biomarker and functional data.
The update follows Dyne&#8217;s January announcement of new data from its ongoing Phase 1/2 ACHIEVE trial of DYNE-101 in DM1 patients, reinforcing the company&#8217;s progress toward key clinical milestones.
&#8220;From our perspective, we continue to ponder management&#8217;s decision to proceed with the registrational expansion cohort for DM1 without receiving regulatory blessing on the protocol and relying on prior dialogue from May 2024 to pursue an accelerated approval path in the U.S,&#8221; Romero writes.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44286904/dyne-therapeutics-4-3-billion-peak-sales-potential-analyst-highlights-key-strengths-and-risks" rel="noreferrer noopener">Dyne Therapeutics&#8217; $4.3 Billion Peak Sales Potential? Analyst Highlights Key Strengths And Risks</a>
&#8220;Based on our conversations, it seems like investors generally share our sentiment and are looking for regulatory sign-off to gain more comfort,&#8221; the analyst added.
Romero still has concerns about the existing data and the absence of a recent update or near-term plans for another data release (the last one was on Dec. 6, 2024).
JPMorgan is also considering how these results might impact the expansion cohort, the confirmatory trial, and the broader competitive landscape.
&#8220;Overall, the additional results from the phase 1/2 ACHIEVE trial evaluating DYNE-101 in DM1 raised more questions than answers for us around the emerging clinical profile, and we look for progress that definitively derisks the lead asset and regulatory strategy,&#8221; the analyst writes.
JPMorgan maintains the Neutral rating on DYN, lowering the price target from $18 to $17.
Price Action: DYN stock is down 1.6% at $12.06 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44439352/fda-approves-expanded-use-of-novartis-rare-disease-drug-as-only-treatment-for-rare-type-of-kidney-disease" target="_blank" rel="noreferrer noopener">FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Biotech

Health Care

JPMorgan Seeks Clarity On Dyne Therapeutics' DYNE-101 Expansion, Regulatory Path

MicroAlgo Shares Halted On Circuit Breaker To The Downside, Stock Now Down -24.4%

SMCI

Super Micro Computer shares are trading higher after JP Morgan upgraded the stock from Underweight to Neutral and raised the price target from $35 to $45.

DA Davidson analyst Michael Baker maintains Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) with a Buy and lowers the price target from $3 to $2.5.

DXLG

DA Davidson Maintains Buy on Destination XL Group, Lowers Price Target to $2.5

MicroAlgo shares are trading lower after the company announced it will issue new stock at an offering price of $0.80 per share to service a convertible bond purchase agreement.

Heathrow Airport CEO Woldbye Says This Has Been An Incident Of Major Severity; Backup Was Working As They Should But They Are Not Designed To Run The Entire Airport; This Has Never Happened Before; The Backup Transformer Also Went Down

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$245.00</td>
<td>$27.8K</td>
<td>12.4K</td>
<td>178.1K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/28/25</td>
<td>$190.00</td>
<td>$48.3K</td>
<td>2.5K</td>
<td>3.3K</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/11/25</td>
<td>$230.00</td>
<td>$217.5K</td>
<td>45</td>
<td>1.0K</td>
</tr>
<tr>
<td>TSCO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$54.00</td>
<td>$69.5K</td>
<td>1.0K</td>
<td>834</td>
</tr>
<tr>
<td>TCOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$65.00</td>
<td>$50.5K</td>
<td>2.6K</td>
<td>497</td>
</tr>
<tr>
<td>CROX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/04/25</td>
<td>$104.00</td>
<td>$61.7K</td>
<td>3</td>
<td>233</td>
</tr>
<tr>
<td>BABA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$110.00</td>
<td>$27.6K</td>
<td>3.8K</td>
<td>139</td>
</tr>
<tr>
<td>WYNN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$82.50</td>
<td>$26.4K</td>
<td>1.2K</td>
<td>78</td>
</tr>
<tr>
<td>SGI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$57.50</td>
<td>$30.8K</td>
<td>203</td>
<td>50</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$150.00</td>
<td>$27.3K</td>
<td>1.0K</td>
<td>20</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a call option sweep that happens to be neutral, is expiring today. Parties traded 107 contract(s) at a $245.00 strike. This particular call needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $27.8K, with a price of $260.0 per contract. There were 12428 open contracts at this strike prior to today, and today 178113 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option sweep with bullish sentiment. It expires in 7 day(s) on March 28, 2025. Parties traded 70 contract(s) at a $190.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $48.3K, with a price of $690.0 per contract. There were 2526 open contracts at this strike prior to today, and today 3380 contract(s) were bought and sold. 
• For CVNA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), we notice a call option trade that happens to be bullish, expiring in 21 day(s) on April 11, 2025. This event was a transfer of 998 contract(s) at a $230.00 strike. The total cost received by the writing party (or parties) was $217.5K, with a price of $218.0 per contract. There were 45 open contracts at this strike prior to today, and today 1002 contract(s) were bought and sold. 
• For TSCO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSCO#NASDAQ">TSCO</a>), we notice a call option sweep that happens to be bullish, expiring in 27 day(s) on April 17, 2025. This event was a transfer of 773 contract(s) at a $54.00 strike. This particular call needed to be split into 37 different trades to become filled. The total cost received by the writing party (or parties) was $69.5K, with a price of $90.0 per contract. There were 1002 open contracts at this strike prior to today, and today 834 contract(s) were bought and sold. 
• For TCOM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>), we notice a put option trade that happens to be bullish, is expiring today. Parties traded 440 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $50.5K, with a price of $115.0 per contract. There were 2678 open contracts at this strike prior to today, and today 497 contract(s) were bought and sold. 
• Regarding CROX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>), we observe a put option sweep with bearish sentiment. It expires in 14 day(s) on April 4, 2025. Parties traded 233 contract(s) at a $104.00 strike. This particular put needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $61.7K, with a price of $265.0 per contract. There were 3 open contracts at this strike prior to today, and today 233 contract(s) were bought and sold. 
• Regarding BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we observe a put option sweep with bearish sentiment. It expires in 91 day(s) on June 20, 2025. Parties traded 120 contract(s) at a $110.00 strike. This particular put needed to be split into 21 different trades to become filled. The total cost received by the writing party (or parties) was $27.6K, with a price of $230.0 per contract. There were 3820 open contracts at this strike prior to today, and today 139 contract(s) were bought and sold. 
• Regarding WYNN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>), we observe a put option sweep with bullish sentiment. It expires in 91 day(s) on June 20, 2025. Parties traded 44 contract(s) at a $82.50 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.4K, with a price of $600.0 per contract. There were 1232 open contracts at this strike prior to today, and today 78 contract(s) were bought and sold. 
• For SGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGI#NYSE">SGI</a>), we notice a put option sweep that happens to be bullish, expiring in 301 day(s) on January 16, 2026. This event was a transfer of 44 contract(s) at a $57.50 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $30.8K, with a price of $700.0 per contract. There were 203 open contracts at this strike prior to today, and today 50 contract(s) were bought and sold. 
• Regarding PDD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), we observe a call option trade with bearish sentiment. It expires in 273 day(s) on December 19, 2025. Parties traded 20 contract(s) at a $150.00 strike. The total cost received by the writing party (or parties) was $27.3K, with a price of $1365.0 per contract. There were 1064 open contracts at this strike prior to today, and today 20 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

AMZN

BABA

CROX

CVNA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TCOM

TSCO

TSLA

WYNN

10 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PFE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$24.00</td>
<td>$50.5K</td>
<td>2.0K</td>
<td>2.0K</td>
</tr>
<tr>
<td>VKTX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$30.00</td>
<td>$60.2K</td>
<td>2.8K</td>
<td>1.6K</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/28/25</td>
<td>$320.00</td>
<td>$473.7K</td>
<td>609</td>
<td>602</td>
</tr>
<tr>
<td>HCA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$320.00</td>
<td>$312.3K</td>
<td>43</td>
<td>502</td>
</tr>
<tr>
<td>AKRO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$27.50</td>
<td>$35.0K</td>
<td>2.4K</td>
<td>469</td>
</tr>
<tr>
<td>GERN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$1.00</td>
<td>$33.7K</td>
<td>413</td>
<td>397</td>
</tr>
<tr>
<td>EWTX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$30.00</td>
<td>$32.2K</td>
<td>5.4K</td>
<td>332</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$230.00</td>
<td>$53.6K</td>
<td>6.9K</td>
<td>295</td>
</tr>
<tr>
<td>CAH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$130.00</td>
<td>$44.2K</td>
<td>2.6K</td>
<td>188</td>
</tr>
<tr>
<td>BMY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$57.50</td>
<td>$64.9K</td>
<td>9.5K</td>
<td>167</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding PFE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), we observe a call option sweep with neutral sentiment. It expires in 56 day(s) on May 16, 2025. Parties traded 200 contract(s) at a $24.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $50.5K, with a price of $253.0 per contract. There were 2012 open contracts at this strike prior to today, and today 2073 contract(s) were bought and sold. 
• For VKTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>), we notice a put option trade that happens to be bearish, is expiring today. Parties traded 300 contract(s) at a $30.00 strike. The total cost received by the writing party (or parties) was $60.2K, with a price of $201.0 per contract. There were 2865 open contracts at this strike prior to today, and today 1625 contract(s) were bought and sold. 
• Regarding AMGN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), we observe a put option sweep with bullish sentiment. It expires in 7 day(s) on March 28, 2025. Parties traded 600 contract(s) at a $320.00 strike. This particular put needed to be split into 57 different trades to become filled. The total cost received by the writing party (or parties) was $473.7K, with a price of $779.0 per contract. There were 609 open contracts at this strike prior to today, and today 602 contract(s) were bought and sold. 
• Regarding HCA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>), we observe a put option sweep with bearish sentiment. It expires in 27 day(s) on April 17, 2025. Parties traded 474 contract(s) at a $320.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $312.3K, with a price of $660.0 per contract. There were 43 open contracts at this strike prior to today, and today 502 contract(s) were bought and sold. 
• For AKRO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKRO#NASDAQ">AKRO</a>), we notice a call option trade that happens to be bearish, is expiring today. Parties traded 20 contract(s) at a $27.50 strike. The total cost received by the writing party (or parties) was $35.0K, with a price of $1750.0 per contract. There were 2499 open contracts at this strike prior to today, and today 469 contract(s) were bought and sold. 
• Regarding GERN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>), we observe a call option trade with bearish sentiment. It expires in 210 day(s) on October 17, 2025. Parties traded 397 contract(s) at a $1.00 strike. The total cost received by the writing party (or parties) was $33.7K, with a price of $85.0 per contract. There were 413 open contracts at this strike prior to today, and today 397 contract(s) were bought and sold. 
• Regarding EWTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWTX#NASDAQ">EWTX</a>), we observe a call option sweep with bullish sentiment. It expires in 27 day(s) on April 17, 2025. Parties traded 104 contract(s) at a $30.00 strike. This particular call needed to be split into 21 different trades to become filled. The total cost received by the writing party (or parties) was $32.2K, with a price of $310.0 per contract. There were 5479 open contracts at this strike prior to today, and today 332 contract(s) were bought and sold. 
• For ABBV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), we notice a call option sweep that happens to be bearish, expiring in 91 day(s) on June 20, 2025. This event was a transfer of 198 contract(s) at a $230.00 strike. This particular call needed to be split into 35 different trades to become filled. The total cost received by the writing party (or parties) was $53.6K, with a price of $271.0 per contract. There were 6965 open contracts at this strike prior to today, and today 295 contract(s) were bought and sold. 
• For CAH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>), we notice a call option sweep that happens to be bullish, is expiring today. Parties traded 137 contract(s) at a $130.00 strike. This particular call needed to be split into 14 different trades to become filled. The total cost received by the writing party (or parties) was $44.2K, with a price of $325.0 per contract. There were 2600 open contracts at this strike prior to today, and today 188 contract(s) were bought and sold. 
• Regarding BMY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>), we observe a call option sweep with bearish sentiment. It expires in 91 day(s) on June 20, 2025. Parties traded 116 contract(s) at a $57.50 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $64.9K, with a price of $560.0 per contract. There were 9548 open contracts at this strike prior to today, and today 167 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABBV

AKRO

AMGN

EWTX

GERN

VKTX

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Information Technology sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$118.00</td>
<td>$29.0K</td>
<td>97.0K</td>
<td>37.5K</td>
</tr>
<tr>
<td>CSCO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$60.00</td>
<td>$38.2K</td>
<td>17.4K</td>
<td>6.8K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/28/25</td>
<td>$42.00</td>
<td>$91.8K</td>
<td>17.9K</td>
<td>6.0K</td>
</tr>
<tr>
<td>ZS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$185.00</td>
<td>$1.2 million</td>
<td>392</td>
<td>3.0K</td>
</tr>
<tr>
<td>AAPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$210.00</td>
<td>$29.3K</td>
<td>34.2K</td>
<td>2.7K</td>
</tr>
<tr>
<td>MSTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/28/25</td>
<td>$280.00</td>
<td>$58.5K</td>
<td>2.1K</td>
<td>1.7K</td>
</tr>
<tr>
<td>CLS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$97.50</td>
<td>$63.0K</td>
<td>651</td>
<td>603</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/28/25</td>
<td>$310.00</td>
<td>$50.9K</td>
<td>2.0K</td>
<td>523</td>
</tr>
<tr>
<td>JKS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$22.50</td>
<td>$156.0K</td>
<td>0</td>
<td>400</td>
</tr>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$25.00</td>
<td>$31.1K</td>
<td>1.9K</td>
<td>372</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a put option sweep that happens to be bullish, is expiring today. Parties traded 255 contract(s) at a $118.00 strike. This particular put needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $29.0K, with a price of $114.0 per contract. There were 97048 open contracts at this strike prior to today, and today 37539 contract(s) were bought and sold. 
• For CSCO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), we notice a put option sweep that happens to be bullish, is expiring today. Parties traded 1418 contract(s) at a $60.00 strike. This particular put needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $38.2K, with a price of $27.0 per contract. There were 17403 open contracts at this strike prior to today, and today 6889 contract(s) were bought and sold. 
• For SMCI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), we notice a call option sweep that happens to be neutral, expiring in 7 day(s) on March 28, 2025. This event was a transfer of 473 contract(s) at a $42.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $91.8K, with a price of $194.0 per contract. There were 17922 open contracts at this strike prior to today, and today 6051 contract(s) were bought and sold. 
• Regarding ZS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>), we observe a put option trade with bullish sentiment. It expires in 56 day(s) on May 16, 2025. Parties traded 2775 contract(s) at a $185.00 strike. The total cost received by the writing party (or parties) was $1.2 million, with a price of $435.0 per contract. There were 392 open contracts at this strike prior to today, and today 3025 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a put option sweep that happens to be bearish, expiring in 91 day(s) on June 20, 2025. This event was a transfer of 33 contract(s) at a $210.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $29.3K, with a price of $890.0 per contract. There were 34243 open contracts at this strike prior to today, and today 2760 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a put option sweep that happens to be bullish, expiring in 7 day(s) on March 28, 2025. This event was a transfer of 100 contract(s) at a $280.00 strike. This particular put needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $58.5K, with a price of $585.0 per contract. There were 2161 open contracts at this strike prior to today, and today 1761 contract(s) were bought and sold. 
• For CLS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>), we notice a call option trade that happens to be neutral, expiring in 27 day(s) on April 17, 2025. This event was a transfer of 100 contract(s) at a $97.50 strike. The total cost received by the writing party (or parties) was $63.0K, with a price of $630.0 per contract. There were 651 open contracts at this strike prior to today, and today 603 contract(s) were bought and sold. 
• Regarding APP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), we observe a call option sweep with bullish sentiment. It expires in 7 day(s) on March 28, 2025. Parties traded 49 contract(s) at a $310.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $50.9K, with a price of $1040.0 per contract. There were 2010 open contracts at this strike prior to today, and today 523 contract(s) were bought and sold. 
• Regarding JKS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>), we observe a put option trade with neutral sentiment. It expires in 182 day(s) on September 19, 2025. Parties traded 400 contract(s) at a $22.50 strike. The total cost received by the writing party (or parties) was $156.0K, with a price of $390.0 per contract. There were 0 open contracts at this strike prior to today, and today 400 contract(s) were bought and sold. 
• For IONQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), we notice a put option trade that happens to be bearish, is expiring today. Parties traded 100 contract(s) at a $25.00 strike. The total cost received by the writing party (or parties) was $31.1K, with a price of $311.0 per contract. There were 1955 open contracts at this strike prior to today, and today 372 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

CSCO

IONQ

MSTR

NVDA

10 Information Technology Stocks With Whale Alerts In Today's Session

Offerings

Press Releases

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

GRAIL to Announce Fourth Quarter 2024 Financial Results

Small Cap

Opinion

Investors Eye Biotech Sector as Cancer Therapy Market Surges

Earnings

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

ONCY

POAI

RENB

TSX:ONC

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

Bicara Therapeutics

CareDx

Chimerix

Cogent Biosciences

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Geron

Gyre Therapeutics

Immunome

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

LENZ Therapeutics

MiMedx Group

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

Myriad Genetics

Nurix Therapeutics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Arcus Biosciences

Replimune Group

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Spyre Therapeutics

Vir Biotechnology

Xencor

Zymeworks

Morgan Stanley

캘리포니아주 멘로파크에 본사를 둔 미국의 생명공학 회사인 그레일(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAL#NASDAQ">GRAL</a>)의 주식은 회사가 임상 실험 연구 기업인 퀘스트 다이아그노스틱스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>)와의 새로운 협업을 발표한 후 수요일 18% 이상 급등 마감했다.
이번 파트너십은 제공자들이 <a href="https://www.benzinga.com/pressreleases/25/01/n42964119/patient-reported-outcomes-for-grails-galleri-multi-cancer-early-detection-blood-test-published-in-">갈레리(Galleri) 다중암 조기 검출 테스트</a>에 더 쉽게 접근할 수 있도록 하는 것을 목표로 한다.
알아야 할 사항: 이번 조치는 검사 주문 과정을 간소화하고 퀘스트의 전국 네트워크를 통해 가용성을 확장할 것으로 기대되지만, 투자자 반응은 그레일의 사업에 미치는 즉각적인 영향에 대한 우려를 나타낸다.
그레일과 퀘스트 다이아그노스틱스는 의사들이 퀘스트의 연결 시스템을 통해 갈레리 테스트를 직접 주문할 수 있는 파트너십의 초기 단계를 공개했다. 이 통합을 통해 500,000명 이상의 제공자가 다른 혈액 검사와 마찬가지로 퀘스트의 쿼텀(Quanum) 실험실 포털과 900개 이상의 전자 건강 기록 시스템을 통해 원활하게 테스트를 요청할 수 있다. 환자들은 테스트 키트를 혈액 채취 약속에 가져갈 필요 없이 퀘스트의 7,400개 위치 중 어느 곳에서나 테스트를 받을 수 있다.
그레일의 사장 조쉬 오프먼(Josh Ofman)은 이 확장의 중요성을 강조하며 조기 발견이 암 치료 결과를 개선하는 데 중요하다고 언급했다.
그는 다섯 가지 암에 대해서만 검진이 확립되어 있는 반면, 암 관련 사망자의 거의 70%는 권장 검진 테스트가 없는 암에서 발생한다고 지적했다. 갈레리 테스트를 정기 검사에 통합함으로써 그레일과 퀘스트는 이 격차를 해소하고 조기 발견을 더 쉽게 접근할 수 있도록 하려 한다.
퀘스트의 수석 부사장 마크 가드너(Mark Gardne)는 이번 협력이 2021년 이후 진행해 온 테스트 접근성 확장 노력을 바탕으로 한다고 강조했다. 그는 새로운 주문 프로세스가 의료 제공자 간의 채택을 간소화하여 갈레리를 표준 암 검진 프로토콜에 통합하기 쉽게 만들 것이라고 밝혔다.
갈레리 테스트는 혈류에서 암 신호를 감지하여 종양이 떨어뜨린 DNA 조각을 식별함으로써 여러 유형의 암을 증상이 나타나기 전에 비침습적으로 선별할 수 있는 방법을 제공한다. 이 테스트는 처방전 전용이며, 50세 이상의 고위험 성인에게 권장된다.
주가 동향: 그레일의 주식은 수요일 18.43% 급등한 39.26달러에 마감되었다.
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021225&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" class="wp-image-779657" style="width: 478px; height: auto;" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-1024x523.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-1024x523.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59-768x393.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12154323/Screenshot-2025-02-12-at-15.42.59.png 1536w" alt="" width="1024" height="523" /></a></figure>
다음 읽기:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/02/43673047/gilead-ups-2025-outlook-eyes-lenacapavir-launch-for-hiv-prevention">길리어드, 2025 전망 상향 조정, 레나카파비르 HIV 예방 출시 목표</a></li>
</ul>
이미지 출처: Shutterstock.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

GRAIL

뉴스

에 대한 최신 뉴스 GRAIL (NASDAQ:GRAL) 주식

수요일, 2월 12, 2025

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌